Protalix BioTherapeutics

PLX

Börsenwert 206 Mio. $

#	Name	Position	Handelswert	Veränderung Aktien	Anteils- änderung
1	1 Camber Capital Management Boston, Massachusetts	8,58 Mio. $	–	–	–
2	2 Federated Hermes Pittsburgh, Pennsylvania	7,67 Mio. $	-1,51 Mio. $	-95.295	-13 %
3	3 Baillie Gifford & Co Edinburgh, United Kingdom	7,58 Mio. $	-99.289 $	-6.247	-1 %
4	4 Visium Asset Management New York	2,95 Mio. $	–	–	–
5	5 Menora Mivtachim Holdings Ramat Gan, Israel	1,42 Mio. $	–	–	–
6	DCM 6 DAFNA Capital Management Los Angeles, California	1,41 Mio. $	-59.761 $	-3.760	-3 %
7	7 California Public Employees Retirement System Sacramento, California	945.000 $	–	–	–
8	8 Mivtachim The Workers Social Insurance Fund Tel Aviv, Israel	730.000 $	–	–	–
9	9 Bridgeway Capital Management Houston, Texas	412.000 $	+35.300 $	+2.221	+7 %
10	10 State of Wisconsin Investment Board Madison, Wisconsin	306.000 $	–	–	–
11	11 Morgan Stanley New York	199.000 $	-50.479 $	-3.176	-16 %
12	12 BlackRock Group London, United Kingdom	128.000 $	–	–	–
13	PVH 13 Psagot Value Holdings Tel Aviv, Israel	103.000 $	-56.264 $	-3.540	-29 %
14	14 VanEck Associates New York	79.000 $	+13.557 $	+853	+15 %
15	15 BNP Paribas Financial Markets Paris, France	72.884 $	-17.563 $	-1.105	-15 %
16	16 Jane Street New York	49.000 $	-127.484 $	-8.021	-66 %
17	17 Connor, Clark & Lunn Investment Management (CC&L) Vancouver, British Columbia, Canada	45.000 $	+31.947 $	+2.010	+113 %
18	18 Northern Trust Chicago, Illinois	36.000 $	–	–	–
19	SIM 19 Spark Investment Management New York	35.000 $	+22.363 $	+1.407	+87 %
20	ARTA 20 A.R.T. Advisors New York	31.000 $	–	–	–
21	21 Oppenheimer & Co New York	18.000 $	–	–	–
22	22 Susquehanna International Group Bala Cynwyd, Pennsylvania	15.000 $	+20.026 $	+1.260	Neu
23	23 Goldman Sachs New York	15.000 $	+20.106 $	+1.265	Neu
24	24 Deutsche Bank Frankfurt Am Main Ge, Germany	12.000 $	+17.165 $	+1.080	Neu
25	25 Edmond de Rothschild Holding Chambesy, Switzerland	5.000 $	-5.563 $	-350	-49 %

Protalix BioTherapeutics PLX Börsenwert 206 Mio. $

Protalix BioTherapeutics

PLX

Börsenwert 206 Mio. $